-+ 0.00%
-+ 0.00%
-+ 0.00%

AVACTA THERAPEUTICS - FIRST EFFICACY DATA FROM FOCUS-01 TRIAL WITH AVA6103 EXPECTED IN H1 2027

Reuters·09/16/2026 15:00:59

Please log in to view news